Skip to main content

Table 2 Neuropeptides and CRP in healthy individuals

From: Effects of mindfulness-based interventions on biomarkers in healthy and cancer populations: a systematic review

Reference

Participants

Study design

Interventions

Controls

Follow up

Outcomes

Findings

Oken et al. (2010) [21]

31 Dementia caregivers

RCT (pilot)

MM (N = 10)

6 weeks + common first-week session

Education (N = 11)

6 weeks + common first-week session

Respite (N = 10)

7 weeks respite care

No

IL-6, TNF-α, HS-CRP, salivary cortisol

There were no pre- and post-intervention differences in the levels of HS-CRP between the different intervention conditions (p > 0.05).

Creswell et al. (2012) [35]

40 ≥ 55y

RCT (small)

MBSR (N = 20)

8 weeks

Wait-list Control

(N = 20)

No

IL-6, CRP, pro-inflammatory gene expression

Compared to the control group, a decrease in log-transformed CRP between pre- and post-intervention (p = 0.08).

Gallegos et al. (2013) [36]

200 ≥ 65y

RCT

MBSR (N = 100)

8 weeks

Wait-list Control

(N = 100)

24 weeks

IL-6, IGF-1, IgM and IgG antibody response

There were positive effects of MBSR activities between IGF-1 levels and yoga, and sitting meditation (p < 0.01).

Johnson et al. (2014) [22]

281 Marine infantries

NRCT

MT (N = 147)

8 weeks

Usual training

(N = 134)

No

plasma neuropeptide Y (NPY), norepinephrine

There were no significant pre- and post-intervention differences in plasma concentrations of NPY between MT intervention and the control group.

The MT intervention group had lower plasma concentrations of NPY than the control group after the stressful training (p < 0.01).

  1. Abbreviations: HS-CRP high-sensitivity C-reactive protein, IGF-1, insulin-like growth factor 1, IgG immunoglobulin G, IgM immunoglobulin M, IL interleukin, MBSR mindfulness-based stress reduction, MM Mindfulness meditation intervention, MT Mindfulness Training, Open open trial with a pre-post trial, RCT randomized controlled trial, NRCT non-randomized controlled trial, TNF-α tumour necrosis factor alpha